Most patients need several sequential treatment steps for remission of major...
Major depressive disorder is a major public health problem that affects 7% of the population during any 12-month period and affects around 1 in 6 people throughout their lifetime. A Seminar published...
View ArticleDo women with bulimia have both an eating disorder and a weight disorder?
Researchers at Drexel University have found that a majority of women with bulimia nervosa reach their highest-ever body weight after developing their eating disorder, despite the fact that the...
View ArticleLifestyle study highlights key differences in relapsing and progressive onset MS
Patients with relapsing onset Multiple Sclerosis (MS) who consumed alcohol, wine, coffee and fish on a regular basis took four to seven years longer to reach the point where they needed a walking aid...
View ArticleBariatric surgery dramatically outperforms standard treatment for type 2...
In the first published study of its kind, researchers from the Catholic University/Policlinico Gemelli in Rome, Italy, and NewYork-Presbyterian/Weill Cornell Medical Center found that bariatric surgery...
View ArticleMajority of children affected by allergy-related diseases
(HealthDay) -- A majority of children have one or more allergy-related diseases, including eczema, asthma, and rhinitis, according to research published in the April issue of Allergy.
View ArticleNew fractionated dosing regimen for anticancer drug significantly improves...
Using fractionated doses of the targeted anticancer drug gemtuzumab ozogamicin allows for safer delivery of the drug into patients aged 50-70 years with acute myeloid leukaemia (AML) and substantially...
View ArticleTo prevent leukemia's dreaded return, go for the stem cells
Researchers reporting in the April Cell Stem Cell, a Cell Press publication, have found a way to stop leukemia stem cells in their tracks. The advance in mice suggests that a combination approach to...
View ArticleBrentuximab vedotin effective in large-cell lymphoma
(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a...
View ArticleWhy chemotherapy fails: Scientists show why leukemia often returns
The fight against cancer is not won in a single battle: Long after a cancer has been beaten into remission, it can return. The reason for this is under debate, and much is unclear. New research led by...
View ArticleStudy reports seizure-freedom in 68 percent of juvenile myoclonic epilepsy...
A 25-year follow-up study reveals that 68% of patients with juvenile myoclonic epilepsy (JME) became seizure-free, with nearly 30% no longer needing antiepileptic drug (AED) treatment. Findings...
View ArticleControl of disease activity and biologic treatment increase life expectency...
According to a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, patients with rheumatoid arthritis (RA) who are prescribed biologic treatments have a...
View ArticleLong-term rituximab safe for patients with wegener's
(HealthDay) -- Repeated and prolonged use of rituximab for B-cell depletion to treat relapses or maintain remission is safe and effective in patients with refractory granulomatosis with polyangiitis...
View ArticleNovel technique for delivering multiple cancer treatments may solve hurdle...
Cancers are notorious for secreting chemicals that confuse the immune system and thwarting biological defenses.
View ArticleAdalimumab is a promising therapy for children with Crohn's disease
Adalimumab (an anti-tumor necrosis factor [TNF] antibody) is effective in maintaining remission in certain pediatric patients with Crohn's disease, according to a new study in Gastroenterology, the...
View ArticleA new approach to improving cancer chemotherapy
(Medical Xpress) -- Chemotherapy kills tumor cells, but it also wreaks havoc on the rest of the body. A team of researchers led by Igor Roninson of the South Carolina College of Pharmacy just reported...
View ArticlePay for performance may improve treatment implementation for adolescent...
Pay for performance appears to be associated with improved implementation of an adolescent substance use treatment program, although no significant differences were found in remission status between...
View ArticleStudy identifies potential new class of drug for treating ulcerative colitis
An investigational drug currently under FDA review for the treatment of rheumatoid arthritis has now shown positive results in patients with moderate-to-severe ulcerative colitis, according to...
View ArticleMany options, good outcomes, for early-stage follicular lymphoma
(Medical Xpress) -- A University of Rochester Medical Center study challenges treatment guidelines for early stage follicular lymphoma, concluding that six different therapies can bring a remission,...
View ArticleLawson researcher sings the baby blues
The impact of bipolar disorder during pregnancy has been hotly contended among the research community. Now, a new study from Lawson Health Research Institute and Western University is sorting out the...
View ArticleSome patients with common kidney disease can skip standard treatments
For patients with a common kidney disease who have normal kidney function and only minor urinary abnormalities at the time of diagnosis, the long-term prognosis is excellent and no special treatments...
View Article